Reported 12 months ago
The article discusses the current bull market, highlighting the performance of major indexes and the potential duration of the market. It focuses on two growth stocks for long-term investment: Vertex Pharmaceuticals, known for its success in the cystic fibrosis drug market and its development of gene-editing therapies, and Okta, a cloud-based identity management service catering to remote work needs. The article provides insights into their financial performances and growth prospects.
Source: YAHOO